Regulatory Story
Go to market news section View chart   Print
Company Shire plc
TIDM SHP
Headline

Transaction in Own Shares

Released 07:00 30-Nov-2012
Number 22226-33FC

Transaction in Own Shares

Transaction in Own Shares

November 30, 2012 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"),
announces that in accordance with the authority granted by shareholders at the
Company's Annual General Meeting on April 24, 2012 it purchased 66,424 of its
ordinary shares of 5 pence each ("Ordinary Shares") on November 29, 2012
through both direct purchases of Ordinary Shares and through the purchase of
Ordinary Shares underlying ADRs. The highest and lowest price paid for the
directly acquired Ordinary Shares was 1817.00 pence per share and 1804.00 pence
per share respectively and for those Ordinary Shares acquired though the
purchase of ADRs was 2913.00 cents per share and 2895.00 cents per share
respectively.

The purchased shares will be held as treasury shares. Following the above
purchase, the Company holds 1,995,978 Ordinary Shares as treasury shares and
has 560,545,235 Ordinary Shares in issue (excluding treasury shares).

The purchases were made by an independent third party which makes its trading
decisions independently of, and uninfluenced by the Company.  The independence
of the third party enables the Company to continue to purchase Ordinary Shares
(including Ordinary Shares underlying ADRs) during close periods and other
prohibited periods, should they arise. The third party has been appointed by
the Company to make purchases to December 31, 2013.

For further information please contact:

Investor Relations                                                             
                                                                               
Eric Rojas                              erojas@shire.com     +1 781 482 0999   
                                                                               
Sarah Elton-Farr                        seltonfarr@shire.com +44 1256 894157   

Notes to editors

Shire enables people with life-altering conditions to lead better lives.

Through our deep understanding of patients' needs, we develop and provide
healthcare in the areas of:

  * Behavioral Health and Gastro Intestinal conditions
   
  * Rare Diseases
   
  * Regenerative Medicine
   
as well as other symptomatic conditions treated by specialist physicians.

We aspire to imagine and lead the future of healthcare, creating value for
patients, physicians, policymakers, payors and our shareholders.

                                                                              

Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX

    
Press Release                                     
                                                  
www.shire.com

Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Transaction in Own Shares - RNS